Related Experiment Video
Updated: Aug 22, 2025
Functional Near-Infrared Spectroscopy Hyperscanning Study in Psychological Counseling
Published on: January 17, 2025
The Effects of Cognitive Behavioral Therapy for Insomnia among College Students with Irritable Bowel Syndrome: A
1Department of Nursing, Healthcare Science & Human Ecology, Dong-Eui University, Busan 47340, Korea.
Insights
Cognitive Behavioral Therapy for Insomnia (CBT-I) effectively reduced insomnia and Irritable Bowel Syndrome (IBS) symptoms in college students. This therapy improved sleep quality and quality of life for students with comorbid IBS and insomnia.
Area of Science:
- Psychiatry
- Gastroenterology
- Sleep Medicine
Background:
- Insomnia is a common issue among college students, often co-occurring with Irritable Bowel Syndrome (IBS).
- Comorbid insomnia and IBS can significantly impair academic performance and overall well-being.
Purpose of the Study:
- To develop and evaluate the efficacy of Cognitive Behavioral Therapy for Insomnia (CBT-I) in college students diagnosed with both IBS and insomnia.
- To assess the impact of CBT-I on insomnia severity, IBS symptoms, and quality of life.
Main Methods:
- A randomized controlled trial involving 60 college students with IBS and insomnia.
- Participants were assigned to either a CBT-I intervention group (4 weeks) or a control group.
- Measures included insomnia severity, pre-sleep arousal, sleep-related cognitions/habits, IBS symptom severity, and quality of life.
Main Results:
- The CBT-I group demonstrated significant reductions in insomnia severity, pre-sleep arousal, and IBS symptom severity compared to the control group.
- Improvements were observed in sleep efficiency and quality of life (QOL) for the CBT-I group.
- No significant changes were noted in Interleukin-6 (IL-6) or C-Reactive Protein (CRP) levels between groups.
Conclusions:
- CBT-I is an effective treatment for college students experiencing comorbid IBS and insomnia.
- The therapy successfully reduced insomnia, IBS symptom severity, and improved quality of life in the studied population.
Abstract:
The aim of the study was to develop and evaluate cognitive behavioral therapy for insomnia (CBT-I) among college students with irritable bowel syndrome (IBS). We randomly assigned 60 college students with IBS comorbid insomnia to the experimental group who received CBT-I for 90 min once a week for 4 weeks and the control (non-CBT-I) group. Participants completed self-report measures of insomnia severity, pre-sleep arousal, sleep-related dysfunctional cognitions, maladaptive sleep habits, IBS symptom severity and IBS quality of life (QOL) at baseline, after intervention, and at 3-month follow-up. Sleep pattern, GI symptoms during sleep and Interleukin-6 (IL-6) and C-Reaction Protein (CRP) were measured at baseline and after intervention. The experimental group showed significant decreases in insomnia severity, sleep onset latency, total time in bed, pre-sleep arousal, GI symptoms during sleep, sleep-related dysfunctional cognitions, maladaptive sleep habits, and IBS symptom severity, compared with the control group. This group also showed significant increases in sleep efficiency and IBS QOL compared with the control group. No significant differences were observed between the levels of IL-6 and CRP of both groups. CBT-I for college students with comorbid IBS and insomnia was effective in reducing insomnia, IBS symptom severity, and IBS QOL.
More Related Videos
Related Concept Videos
01:30Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
01:30Irritable Bowel Syndrome III: Medical and Nursing Management
01:17Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
01:21Drugs for Treatment of Constipation-Predominant IBS
01:17Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...